ArriVent BioPharma, Inc. ( AVBP) - Key Metrics
AVBP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.05 | -$0.83 | -$0.83 |
| 2026Q1 | $0 | -$0.96 | -$0.93 | -$0.93 |
| 2025Q4 | $0 | -$0.92 | -$0.80 | -$0.80 |
| 2025Q3 | $0 | -$0.83 | -$0.85 | -$0.85 |
| 2025Q2 | $0 | -$0.90 | -$0.75 | -$0.75 |
AVBP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.27 |
| 2026Q1 | 0% | -6.01 |
| 2025Q4 | 0% | -5.99 |
| 2025Q3 | 0% | -5.56 |
| 2025Q2 | 0% | -6.05 |
AVBP
Price: $16.54
52 week price:
Earnings Per Share: -3.55 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.3 billion